Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INCORPORATED (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our Twin Momentum Investor model based on ...

View Vertex Pharmaceuticals Incorporated (VRTX) current and estimated P/E ratio data provided by Seeking Alpha.

In the case of Vertex, the consensus sales estimate of $2.68 billion for the current quarter points to a year-over-year change of +7.8%. The $10.74 billion and $11.83 billion estimates for the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of biotech company Vertex Pharmaceuticals (VRTX) are down in today’s trading despite the company upping its revenue ...

Vertex Pharmaceuticals (VRTX) closed at $489.43 in the latest trading session, marking a +0.84% move from the prior day. This move outpaced the S&P 500's daily gain of 0.13%. At the same time ...

But Katia Beauchamp's roots veer far from the sparkly beauty industry scene. Fortune cajoled this year's top 40 into sharing facts about them you won't find on the Internet (until now).

However, he sees opportunities outside of the GLP-1 landscape, pointing specifically to Regeneron (REGN) and Vertex (VRTX) as prime examples. Vertex, a leader in cystic fibrosis research ...

1 Day VRTX -2.72% DJIA 0.09% S&P 500 -0.19% Health Care/Life Sciences 0.99% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...